Partners Capital Investment Group’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,917
Closed -$367K 175
2025
Q4
$367K Hold
12,917
0.01% 138
2025
Q3
$314K Hold
12,917
0.01% 146
2025
Q2
$273K Sell
12,917
-12,916
-50% -$265K 0.01% 147
2025
Q1
$547K Buy
25,833
+12,916
+100% +$287K 0.01% 151
2024
Q4
$278K Sell
12,917
-12,916
-50% -$298K 0.01% 122
2024
Q3
$614K Hold
25,833
0.01% 148
2024
Q2
$589K Buy
25,833
+12,916
+100% +$282K 0.01% 155
2024
Q1
$286K Sell
12,917
-12,916
-50% -$286K 0.01% 137
2023
Q4
$565K Buy
25,833
+63
+0.2% +$1.24K 0.01% 169
2023
Q3
$511K Buy
25,770
+53
+0.2% +$1.08K 0.01% 179
2023
Q2
$525K Buy
25,717
+12,887
+100% +$270K 0.01% 167
2023
Q1
$265K Buy
12,830
+24
+0.2% +$503 0.01% 120
2022
Q4
$270K Hold
12,806
0.01% 124
2022
Q3
$242K Buy
+12,806
New +$254K 0.01% 122

Other funds holding IBBQ

Partners Capital Investment Group's IBBQ Position: Q1 2026 in Review

Partners Capital Investment Group sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2026, closing a stake of 12,917 shares — an estimated $367K sold.

Partners Capital Investment Group first reported a position in IBBQ in Q3 2022 and held it in 14 quarters. The position peaked at $614K in Q3 2024. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Partners Capital Investment Group reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Partners Capital Investment Group sold 12,917 Invesco NASDAQ Biotechnology ETF shares in Q1 2026, an estimated $367K.
  • Partners Capital Investment Group first reported a position in Invesco NASDAQ Biotechnology ETF in Q3 2022 and held it in 14 quarters.
  • Partners Capital Investment Group's Invesco NASDAQ Biotechnology ETF position peaked at $614K in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Partners Capital Investment Group's 13F filing for Q1 2026, filed 12 May 2026.